Monday, September 25, 2023

DSM completes its acquisition of Biomin and Romer Labs

Must read

OVERLAND PARK, Kan. — Royal DSM, a global science-based company in nutrition, health and sustainable living, has announced the completion of its acquisition of Erber Group’s Biomin and Romer Labs for an enterprise value of €980 million (approximately $1.1 billion).

The transaction, first announced on June 12, 2020, forecasted enhanced earnings in the first year upon completion, the company said.

Biomin, a specialty animal nutrition and health business, specializes primarily in mycotoxin risk management and gut health performance. The acquisition of Biomin further strengthens DSM’s expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency, and better use of water and land, the company noted, adding that it is therefore aligned closely with DSM’s focus to make animal farming more sustainable from both an ecological and economical perspective.

The Romer Labs business focuses on food and feed safety diagnostic solutions. Romer Labs also complements DSM’s human nutrition and health offering to customers in the food and beverage market segments, the company said. Both entities expand DSM’s range of higher value-add specialty solutions.

Royal DSM notes that its purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders: customers, employees, shareholders and society at large, the company says, adding that it delivers solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at

Biomin, part of Erber Group, is a leading research company and producer of feed additives in the poultry, swine, and ruminant markets, operating in more than 120 countries. Well-known for closely examining and identifying mycotoxins, Biomin offers technologies to deliver natural and profitable solutions. Biomin experts also partner with customers to explore gut health challenges and offers a line of products in the phytogenics, probiotics, organic acids, and yeast categories, the company notes, adding that for the past 30 years, it has been committed to pioneering solutions that will help maximize animal health and performance. For more information about Biomin, visit,

More articles

Latest article